Fisiopatología y tratamiento de las enfermedades neurodegenerativas

Publicaciones destacadas

Ikzf1 as a novel regulator of microglial homeostasis in inflammation and neurodegeneration

Ballasch, I; García-García, E; Vila, C; Pérez-González, A; Sancho-Balsells, A;

(...)

Gasull, X; Alberch, J; Rodríguez, MJ; Canals, JM; Giralt, A.

Referencia:
Brain Behavior And Immunity 2023.
GPC3-Unc5 receptor complex structure and role in cell migration

Akkermans, O; Delloye-Bourgeois, C; Peregrina, C; Carrasquero-Ordaz, M; Kokolaki, M;

(...)

Owens, RJ; Robinson, CV; Castellani, V; del Toro, D; Seiradake, E.

Referencia:
Cell 2022.
Altered m6A RNA methylation contributes to hippocampal memory deficits in Huntington's disease mice

Pupak, A; Singh, A; Sancho-Balsells, A; Alcalá-Vida, R; Espina, M;

Giralt, A; Martí, E; Orom, UAV; Ginés, S; Brito, V.

Referencia:
Cellular And Molecular Life Sciences 2022.
Translating cell therapies for neurodegenerative diseases: Huntington's disease as a model disorder

Rosser, AE; Busse, ME; Gray, WP; Badin, RA; Perrier, AL;

(...)

Mills, LJ; Drew, C; Goldman, SA; Canals, JM; Thompson, LM.

Referencia:
Brain 2022.
Huntington’s disease brain-derived small RNAs recapitulate associated neuropathology in mice

Creus-Muncunill, J; Guisado-Corcoll, A; Venturi, V; Pantano, L; Escaramís, G;

(...)

Masana, M; Llorens, F; Diaz-Lucena, D; Pérez-Navarro, E; Martí, E.

Referencia:
Acta Neuropathologica 2021.
Neuron type-specific increase in lamin B1 contributes to nuclear dysfunction in Huntington's disease

Alcalá-Vida, R; Garcia-Forn, M; Castany-Pladevall, C; Creus-Muncunill, J; Ito, Y;

(...)

Samarajiwa, S; Peiró, S; Di Croce, L; Narita, M; Pérez-Navarro, E.

Referencia:
Embo Molecular Medicine 2021.
M2 cortex-dorsolateral striatum stimulation reverses motor symptoms and synaptic deficits in Huntington's disease

Fernandez-Garcia, Sara; Conde-Berriozabal, Sara; Garcia-Garcia, Esther; Gort-Paniello, Clara; Bernal-Casas, David;

(...)

Campa, Leticia; Artigas, Francesc; Jose Rodriguez, Manuel; Alberch, Jordi; Masana, Merce.

Referencia:
Elife 2020.
Increased translation as a novel pathogenic mechanism in Huntington's disease

Creus-Muncunill J; Badillos-Rodríguez R; Garcia-Forn M; Masana M; Barriga G;

(...)

Alberch J; Malagelada C; Delgado-García J; Gruart A; Pérez-Navarro E.

Referencia:
Brain 2019.
Cyclin-Dependent Kinase 5 Dysfunction Contributes to Depressive-like Behaviors in Huntington's Disease by Altering the DARPP-32 Phosphorylation Status in the Nucleus Accumbens

Brito V; Giralt A; Masana M; Royes A; Espina M;

Sieiro E; Alberch J; Castañé A; Girault J; Ginés S.

Referencia:
Biological Psychiatry 2019.
Phosphorylation of huntingtin at residue T3 is decreased in Huntington's disease and modulates mutant huntingtin protein conformation.

Cariulo C; Azzollini L; Verani M; Martufi P; Boggio R;

(...)

Santimone I; Squitieri F; Lashuel HA; Petricca L; Caricasole A .

Referencia:
Proceedings Of The National Academy Of Sciences Of The United States Of America 2017.